New micromotion nail could speed up shinbone healing

NCT ID NCT06679049

Recruiting now Disease control Sponsor: University of Alabama at Birmingham Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jul 15, 2026 · Updated 6 times

Summary

This study compares a standard metal rod (nail) used to fix shinbone fractures with a new 'micromotion' nail that allows a tiny amount of movement at the break. Researchers want to see if the new nail helps bones heal faster and with fewer problems. About 100 adults with stable shin fractures will be randomly assigned to receive either the standard or micromotion nail.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: micromotion intramedullary nail (a device that allows slight movement at the fracture site)
What this could lead to: If successful, this could lead to faster and more reliable healing of shinbone fractures, reducing the need for additional surgeries.
What could go wrong: This is a relatively small, early-stage trial with only 100 participants, so results may not apply to everyone. The new nail may not improve healing and could have unforeseen complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TIBIAL FRACTURES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

tibia fracture

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TIBIAL FRACTURES

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

University of Alabama at Birmingham Main Hospital
RECRUITING

Birmingham, Alabama, 35294, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.